Extractables Screening of Polypropylene Resins Used in Pharmaceutical Packaging for Safety Hazards

Reference

1. 1.↵
   ISO 10993-12:2012(E). Biological Evaluation of Medical Devices—Part 12: Sample Preparation and Reference Materials. Fourth edition, 2012-07-01.
2. 2.↵
   1. Cramer G. M.,
   2. Ford R. A.,
   3. Hall R. L.

   Estimation of Toxic Hazard—A Decision Tree Approach. Food Cosmet. Toxicol. 1978, 16 (3), 255–276.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   Toxtree (Estimation of Toxic Hazard—A Decision Tree Approach), Version 2.6.0. Ideaconsult Ltd.: Sofia, Bulgaria.
4. 4.↵
   1. Benigni R.,
   2. Bossa C.,
   3. Jeliakova N.,
   4. Netzeva T.,
   5. Worth A.

   The Benigni/Bossa Rulebase for Mutagenicity and Carcinogenicity—A Module of Toxtree. EUR 23241EN -2008. The European Commission: Luxembourg, 2008.
5. 5.↵
   University of California, Berkeley. Carcinogenic Potency Database. Available at http://toxnet.nlm.nih.gov/cpdb/chemnameindex.html. Updated October 3, 2007. Accessed September 27, 2016.
6. 6.↵
   Toxnet Toxicology Data Network, Chemical Carcinogenesis Research Information (CCRIS). Available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS. Accessed September 27, 2016.
7. 7.
   1. Li K.,
   2. Rogers G.,
   3. Nashed-Samuel Y.,
   4. Lee H.,
   5. Mire-Sluis A.,
   6. Cherney B.,
   7. Forster R.,
   8. Yeh P.,
   9. Markovic I.

   Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products. PDA J. Pharm. Sci. Technol. 2015, 69 (5), 590–619.

   OpenUrlAbstract/FREE Full Text
8. 8.
   European Chemicals Agency EC# 402-140-1 entry for CAS 17865-32-6. Exp Supporting Repeated Dose Toxicity: Oral. 002. http://www.echa.europa.eu/web/guest/registration-dossier/∼/registered-dossier/8528.
9. 9.
   Dicyclopentylsilanediol [CAS No. 211495-85-1]. Abstract for 90-day Repeat Dose Oral Toxicity Study in Rats. Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd. (14 Sunayama, Hasaki-machi, Kashima-gun, Ibaraki, 314-0255, Japan).
10. 10.
    OECD HPV Chemical Programme, SIDS Dossier, Benzoates. Available at http://webnet.oecd.org/HPV/UI/SIDS_Details.aspx?key=78d737a4-1363-4f31-8de6-9a0c4225c240&idx=0. Accessed on March 10, 2014.
11. 11.
    Hazardous Substances Database (HSDB). Nonanoic Acid CAS No. 112-05-0. Hazardous Substances Databank Number 5554. Late revision date: October 7, 2008.
12. 12.
    1. Colomina M. T.,
    2. Gómez M.,
    3. Domingo J. L.,
    4. Llobet J. M.,
    5. Corbella J.

    Concurrent Ingestion of Lactate and Aluminum Can Result in Developmental Toxicity in Mice. Res. Commun. Chem. Pathol. Pharmacol. 1992, 77 (1), 95–106.

    OpenUrlPubMed
13. 13.
    IUCLID Dataset. Myristic Acid, pure. CAS Registry No. 544-63-8) EINCES No. 208-875-2. European Commission—European Chemicals Bureau. January 23, 2008.
14. 14.
    Final Report on the Safety Assessment of Oleic Acid, Lauric Acid, Palmitic Acid, Myristic Acid and Stearic Acid. Int J. Toxicol. 1987, 6 (3), 321–401.

    OpenUrlCrossRef
15. 15.
    IUCLID Dataset on fatty acids, rape oil. European Commission–European Chemical Bureau. February 19, 2000.
16. 16.
    Safety Data Sheet, Stearic Acid. Product code 10011298. CAS # 57-11-4; RTECS No. WI2800000. Cayman Chemical Co., 1180 E. Ellsworth Rd, Ann Arbor, MI, 48108. Revision date 07/20/2015.
17. 17.
    Japan Existing Chemical Data Base. 2,4-Di-ter-butylphenol. http://dra4.nihs.go.jp/mhlw_data/home/file/file96-76-4.html. Accessed April 6, 2011.
18. 18.
    United Nations Environmental Program. 2,6-di-tert-butyl-p-cresol (BHT) CAS No 128-37-0 http://www.inchem.org/documents/sids/sids/128370.pdf. Accessed April 12, 2011. Article reference: DFG (1985): Toxikologisch-arbeitsmedizinische Begründung von MAK-Werten – Butylhydroxytoluol (BHT), Deutsche Forschungsgemeinschaft (DFG), VCH Weinheim.
19. 19.
    1. Takahashi O.

    Haemorrhages due to Defective Blood Coagulation Do Not Occur in Mice and Guinea Pigs Fed Butylated DHdroxytoluene, but Nephrotoxicity Is Found in Mice. Food Chem. Toxicol. 1992, 30 (2), 89–97.

    OpenUrlPubMedWeb of Science
20. 20.
    Screening-Level hazard Characterization of High Production Volume Chemicals. Tris(2,4-di-(tert)-butylphenylphosphite (CAS No. 31570-04-4). December 2007. Interim. Prepared by the High Production Volume Chemicals Branch, Risk Assessment Division, Office of Pollution Prevention and Toxics, Environmental Protection Agency, Washington, DC.
21. 21.
    European Chemicals Agency EC#204-009-2 entry for CAS 112-84-5. (Z)-Docos-13-enamide. Exp Key Repeated dose toxicity: Oral.001. http://apps.echa.europa.eu/registered/data/dossiers/DISS-98762a7c-c98a-014e-e044-00144f67d031/AGGR-6c9d6a4d-ceff-4d77-97a9-f0c6eb07c935_DISS-98762a7c-e98a-014e-e044-00144f67d031.html#AGGR-6c9d6a4d-ceff-4d77-97a9-f0c6eb07c935.
22. 22.
    Registry of Toxic Effects of Chemical Substances (RTECS). Urea. CAS Registry No. 57-13-6. RTECS No. YR6250000. Review date: July, 2013.
23. 23.
    OECD SIDS Initial Assessment Report for SIAM 14. Glycerol, CAS Number 56-81-5. Sponsor Country: United Kingdom. Submitted February, 2002.
24. 24.
    Safety Data Sheet, Dithiothreitol. Product code. CAS # 3483-12-3; RTECS No. EK1610000. Fisher Scientific, 1 Research Lane, Fair Lawn, NJ, 48108. Revision date 07/29/2008.
25. 25.
    IUCLID Dataset. Dodecan-1-ol. CAS Registry No. 112-53-8. EINECS No. 203-982-0. European Commission–European Chemicals Bureau. February 18, 2000.
26. 26.
    European Chemicals Agency. (Publication dated 1982 [Gorzinski et al, 1982]). REACH registration dossier for dodecyl acrylate CAS No.: 2156-97-0. Read across Subs Supporting Repeated Dose Toxicity: oral.003. Accessed July 1, 2014.
27. 27.
    1. Yamada A.

    Toxicity of Phthalic Acid Esters and Hepatotoxicity of Di-(2-ethylhexyl) Phthalate. J. Food Hyg. Soc. Japan. 1974, 15 (3), 147–152.

    OpenUrl
28. 28.
    National Toxicology Program. 1984. Diethyl phthalate: Reproduction and Fertility Assessment in CD-1 Mice When Administered in the Feed. NTP-84-262. U.S. Department of Health and Human Services, National Institutes of Health, NTP, National Institute of Environmental Health Sciences, Research Triangle Park, NC. NTP Report No. RACB83092. Abstract available at http://ntpserver/niehs.nih.gov/index.cfm?objectid=071C4778-DDD3-7EB0-D932FD19ABCD6353.
29. 29.
    IUCLID Dataset. Octandecan-1-o1. CAS Registry No. 112-92-5. EINECS No. 204-017-6. European Commission–European Chemicals Bureau. February 18, 2000.
30. 30.
    Safety Data Sheet, ATMER™ 163. Product code AEK2311. Registration No. 01-2119548392-37-0000. Substance No. 276-014-8. Croda Europe Ltd., Cowick Hall, Snaith, DN14 9AA Goole. Version 1; Revision date 07/12/2010.
31. 31.
    OECD SIDS Initial Assessment Report for SIAM 18. Soluble Silicates. Sponsor Country: Germany. Submitted January, 2004.
32. 32.↵
    Guidance for Industry. M7 Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk. U.S. Department of Health and Human Services, Food and Drug Administration: Rockville, MD, May, 2015.
33. 33.↵
    International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Draft Consensus Guideline. Guideline for Elemental Impurities. Q3D. Current Step 4 Version, December 16, 2014.
34. 34.↵
    1. Jenke D. R.

    Extraction of Stearate Salts from Plastic Materials Used in Pharmaceutical Applications. PDA J. Pharm. Sci. Technol. 2010, 64 (3), 200–210.

    OpenUrlAbstract/FREE Full Text
35. 35.↵
    1. Jenke D. R.

    Extractable/Leachable Substances from Plastic Materials Used as Pharmaceutical Product Containers/Devices. PDA J. Pharm. Sci. Technol. 2002, 56 (6), 332–371.

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    1. Jenke D. R.

    Extractable Substances from Plastic Materials Used in Solution Contact Applications. An updated review. PDA J. Pharm. Sci. Technol. 2006, 60 (3), 191–207.

    OpenUrlAbstract/FREE Full Text
37. 37.↵
    1. Jenke D. R.,
    2. Stults C. L. M,
    3. Paskiet D. M.,
    4. Ball D. J.,
    5. Nagao L. M.

    Materials in Manufacturing and Packaging Systems as Sources of Elemental Impurities in Packaged Drug Products: A Literature Review. PDA J. Pharm. Sci. Technol. 2015, 69 (1), 1–48.

    OpenUrlAbstract/FREE Full Text
38. 38.↵
    1. Jenke D.,
    2. Couch T. R.,
    3. Robinson S. J.,
    4. Volz T. J.,
    5. Colton R. H.

    The Use of TOC Reconciliation as a Means of Establishing the Degree to Which Chromatographic Screening of Plastic Material Extracts for Organic Extractables Is Complete. PDA J. Pharm. Sci. Technol. 2014, 68 (3), 256–270.

    OpenUrlAbstract/FREE Full Text
39. 39.↵
    1. Broschard T. H.,
    2. Glowienke S.,
    3. Bruen U. S.,
    4. Nagao L. M.,
    5. Teasdale A.,
    6. Stults C. L.,
    7. Li K. L.,
    8. Iciek L. A.,
    9. Erexson G.,
    10. Martin E. A.,
    11. Ball D. J.

    Assessing Safety of Extractables from Materials and Leachables in Pharmaceuticals and Biologics—Current Challenges and Approaches. PDA J. Pharm. Sci. Technol. 2016, 81, 201–211.

    OpenUrl
40. 40.↵
    Integrated Risk Information System, U.S. Environmental Protection Agency. Boron (CASRN 7440-42-8). August 5, 2004. Available at http://www.epa.gov/iris/subst/0410.htm.
41. 41.↵
    Expert Group on Vitamins and Minerals. EVM/99/23/P—Review of Boron. November, 1999. Available at http://archive.food.gov.uk/dept_health/pdf/evmpdf/evm9923.pdf.
42. 42.↵
    1. Jenke D. R.

    A General Strategy for the Chemical Aspects of the Safety Assessment of Extractables and Leachables in Pharmaceutical Drug Products. The Chemical Assessment Triad. PDA J. Pharm. Sci. Technol. 2012, 66 (2), 168–183.

    OpenUrlAbstract/FREE Full Text
43. 43.↵
    USP. <1661> Evaluation of Plastic Packaging Systems and their Materials of Construction with Respect to Their User Safety Impact. USP39-NF 34; pp 1823–1827. Official May 1, 2016.